Article

Patent Ductus Arteriosus (PDA) and Response to Late Surfactant Treatment in Premature Infants Running Title: Ductus Arteriosus and Late Surfactant Treatment

2022-10-04

Abstract excerpt

<title>Abstract</title> <p><bold>Objective</bold> To determine clinical/echocardiography (ECHO) phenotype of response to late surfactant, according to patent ductus arteriosus (PDA) status. <bold>Study Design</bold> Infants ≤26<sup>+6</sup> weeks gestational age (GA), who received ≥1 surfactant dose after postnatal day 6 with known PDA status, were enrolled. Response to surfactant, based on change in respiratory...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 33a6f0c6-8101-5d9a-b38f-40bc2089fd3e
DOI: 10.21203/rs.3.rs-2098003/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Patent Ductus Arteriosus (PDA) and Response to Late Surfactant Treatment in Premature Infants Running Title: Ductus Arteriosus and Late Surfactant TreatmentDOI 10.21203/rs.3.rs-2098003/v1Read

Factors Associated with Short-Term Response after Systemic Corticosteroid Treatment in Invasively Ventilated Preterm InfantsSemantic proximity Read

Clinical Phenotype of Pulmonary Vascular Disease Requiring Treatment in Extremely Preterm InfantsSemantic proximity Read

Application of NPE in the assessment of a patent ductus arteriosus.Semantic proximity Read

Updates on Management for Acute and Chronic Phenotypes of Neonatal Pulmonary Hypertension.Semantic proximity Read

Pulmonary Hemorrhage in Premature Infants: Pathophysiology, Risk Factors and Clinical ManagementSemantic proximity Read

Clinical phenotype of pulmonary vascular disease requiring treatment in extremely preterm infants.Semantic proximity Read

Biochemical markers may identify preterm infants with a patent ductus arteriosus at high risk of death or severe intraventricular haemorrhageSemantic proximity Read

Genetics of the patent ductus arteriosus (PDA) and pharmacogenetics of PDA treatment.Semantic proximity Read

Surfactant Protein A and B Gene Polymorphisms and Risk of Respiratory Distress Syndrome in Late-Preterm Neonates.Semantic proximity Read

Spontaneous Achievers, Responders and Non-Responders: Aligning Treatment With the Natural History of Bronchopulmonary Dysplasia in Preterm Infants.Semantic proximity Read

Patent Ductus Arteriosus and Lung Magnetic Resonance Imaging Phenotype in Moderate and Severe Bronchopulmonary Dysplasia-Pulmonary Hypertension.Semantic proximity Read

Early versus delayed selective surfactant treatment for neonatal respiratory distress syndromeSemantic proximity Read